Project Details
Description
An Open-Label, Multiple Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CP-690,550 in Pediatric Patients from 2 to Less than 18 Years of Age with Juvenile Idiopathic Arthritis (JIA)
Status | Finished |
---|---|
Effective start/end date | 4/1/14 → 4/30/19 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.